A+ A-

 

Bulletin TREND | COVID-19 n°2
Drug use, drug supply and professional practices in France at the time of COVID-19: qualitative cross-observations of the TREND scheme

 

Bulletin-TREND-COVID-19-N-2.jpg

Memo, OFDT, 6 p.
N° 2 - April-May 2020

The development of the COVID-19 epidemic and the implementation of lockdown measures by the French public authorities in mid-March 2020 changed the consumption practices of drug users and disrupted the activities of trafficking networks.

In order to better understand these developments, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has appealed to the eight local centres in its Emerging Trends and New Drugs (TREND) monitoring system (Bordeaux, Lille, Lyon, Marseille, Metz, Paris, Rennes, Toulouse).

After an initial bulletin covering the first three weeks of lockdown (from mid-March to the first week of April 2020), this updated overview includes the data collected between 7 April and 7 May in order to document in greater detail the following three themes:

  • the adaptation strategies adopted by users (abstinence and forced or consensual withdrawal, overconsumption, compensation and transfers to other products, etc.);
  • the ways in which health care and risk reduction facilities have changed their practices and activities in order to best pursue their missions;
  • and the transformations concerning trafficking networks.

Author : Clément Gérome, Michel Gandilhon

Download the PDF file (679 Ko)

 

 

 

 

 

 

Drugs in Europe


2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.